Over the coming years, the market for stentless bioprostheses is anticipated to increase significantly, mostly due to the rising need for minimally invasive cardiac valves and related technologies. A multitude of variables, including an ageing population, an increase in cardiovascular disease incidence, and technological developments in medical equipment, are fueling this need. Additionally,...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian